Logo Logo

Publications by Schmitz-Valckenberg, Steffen

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 11.

Journal article

Behning, Charlotte; Fleckenstein, Monika; Pfau, Maximilian; Adrion, Christine ORCID: 0000-0003-2408-2533; Goerdt, Lukas; Lindner, Moritz; Schmitz-Valckenberg, Steffen; Holz, Frank G.; Schmid, Matthias (2021): Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation. In: BMC Medical Research Methodology, Vol. 21, 170 [PDF, 1MB]

Pfau, Maximilian; Walther, Guenther; Emde, Leon von der; Berens, Philipp; Faes, Livia; Fleckenstein, Monika; Heeren, Tjebo F. C.; Kortuem, Karsten; Kuenzel, Sandrine H.; Müller, Philipp L.; Maloca, Peter M.; Waldstein, Sebastian M.; Wintergerst, Maximilian W. M.; Schmitz-Valckenberg, Steffen; Finger, Robert P.; Holz, Frank G. (2020): Künstliche Intelligenz in der Augenheilkunde. Leitfaden für Ärzte zur kritischen Bewertung von Studien. In: Ophthalmologe, Vol. 117, No. 10: pp. 973-988

Pielen, Amelie; Feltgen, Nicolas; Hattenbach, Lars-Olof; Hoerauf, Hans; Bertelmann, Thomas; Quiering, Claudia; Voegeler, Jessica; Priglinger, Siegfried; Lang, Gabriele E.; Schmitz-Valckenberg, Steffen; Wolf, Armin; Rehak, Matus (2020): Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials. In: Current Eye Research, Vol. 45, No. 5: pp. 604-614

Gale, Richard P.; Pearce, Ian; Eter, Nicole; Ghanchi, Faruque; Holz, Frank G.; Schmitz-Valckenberg, Steffen; Balaskas, Konstantinos; Burton, Ben J. L.; Downes, Susan M.; Eleftheriadis, Haralabos; George, Sheena; Gilmour, David; Hamilton, Robin; Lotery, Andrew J.; Patel, Nishal; Prakash, Priya; Santiago, Cynthia; Thomas, Saju; Varma, Deepali; Walters, Gavin; Williams, Michael; Wolf, Armin; Zakri, Rosina H.; Igwe, Franklin; Ayan, Filis (2020): Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study. In: British Journal of Ophthalmology, Vol. 104, No. 4: pp. 493-499

Terheyden, Jan H.; Finger, Robert P.; Schmitz-Valckenberg, Steffen; Agostini, HansJürgen; Dahlke, Claudia; Kuehlewein, Laura; Lang, Gabriele E.; Pauleikhoff, Daniel; Wolf, Armin; Boettger, Michael K.; Luhmann, Ulrich F. O.; Asmus, Friedrich; Holz, Frank G.; Asmus, F.; Berger, M.; Binns, A.; Boettger, M.; Bouchet, C.; Brazier, J. E.; Butt, T.; Carapezzi, C.; Carlton, J.; Costa, M.; Crabb, D. P.; Cunha-Vaz, J.; Dunbar, H.; Durbin, M.; Finger, R.; Holz, F.; Hoyng, C.; Kraetzschmar, J.; Luhmann, U.; Luening, A.; Margaron, Ph.; Martinho, C.; Melicio, B.; Normand, G.; Rowen, D.; Rubin, G. S.; Sahel, J.; Sanchez, C. I.; Fernandes, D. Sanches; Schmid, M.; Schmitz-Valckenberg, S.; Skelly, A.; Terheyden, J.; Tufail, A.; Wojek, C.; Zamiri, P. (2019): MACUSTAR: Entwicklung und klinische Validierung von funktionellen, strukturellen und patientenberichteten Endpunkten bei intermediärer altersabhängiger Makuladegeneration. In: Ophthalmologe, Vol. 116, No. 12: pp. 1186-1193

Feltgen, Nicolas; Hattenbach, Lars-Olof; Bertelmann, Thomas; Callizo, Josep; Rehak, Matus; Wolf, Armin; Berk, Hüsnü; Eter, Nicole; Lang, Gabriele E.; Pielen, Amelie; Schmitz-Valckenberg, Steffen; Quiering, Claudia; Rose, Uwe; Hörauf, Hans (2018): Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study. In: Acta Ophthalmologica, Vol. 96, No. 8, E933-E941

Hattenbach, Lars-Olof; Feltgen, Nicolas; Bertelmann, Thomas; Schmitz-Valckenberg, Steffen; Berk, Hüsnü; Eter, Nicole; Lang, Gabriele E.; Rehak, Matus; Taylor, Simon R.; Wolf, Armin; Weiss, Claudia; Paulus, Eva-Maria; Pielen, Amelie; Hörauf, Hans (2018): Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B). In: Acta Ophthalmologica, Vol. 96, No. 1, E10-E18

Paul, Christoph; Heun, Christine; Müller, Hans-Helge; Hörauf, Hans; Feltgen, Nicolas; Wachtlin, Joachim; Kaymak, Hakan; Mennel, Stefan; Koss, Michael Janusz; Fauser, Sascha; Maier, Mathias M.; Schumann, Ricarda G.; Müller, Simone; Chang, Petrus; Schmitz-Valckenberg, Steffen; Kazerounian, Sara; Szurman, Peter; Lommatzsch, Albrecht; Bertelmann, Thomas (2018): Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study. In: British Journal of Ophthalmology, Vol. 102, No. 8: pp. 1092-1097

Bertelmann, Thomas; Wachtlin, Joachim; Mennel, Stefan; Koss, Michael J.; Maier, Mathias M.; Schumann, Ricarda G.; Kazerounian, Sara; Daniel, Hanna; Schmitz-Valckenberg, Steffen (2017): The predictability of ocriplasmin treatment effects: is there consensus among retinal experts? Results from the EXPORT study. In: Graefes Archive for Clinical and Experimental Ophthalmology, Vol. 255, No. 7: pp. 1359-1367

Hoerauf, Hans; Feltgen, Nicolas; Weiss, Claudia; Paulus, Eva-Maria; Schmitz-Valckenberg, Steffen; Pielen, Amelie; Puri, Pankaj; Berk, Hüsnü; Eter, Nicole; Wiedemann, Peter; Lang, Gabriele E.; Rehak, Matus; Wolf, Armin; Bertelmann, Thomas; Hattenbach, Lars-Olof (2016): Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study. In: American Journal of Ophthalmology, Vol. 169: pp. 258-267

Scholl, Hendrik P. N.; Fleckenstein, Monika; Fritsche, Lars G.; Schmitz-Valckenberg, Steffen; Göbel, Arno; Adrion, Christine ORCID: 0000-0003-2408-2533; Herold, Christine; Keilhauer, Claudia N; Mackensen, Friederike; Mössner, Andreas; Pauleikhoff, Daniel; Weinberger, Andreas W. A.; Mansmann, Ulrich; Holz, Frank G.; Becker, Tim; Weber, Bernhard H. F. (2009): CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD.
In: PLOS ONE 4(10), e7418 [PDF, 186kB]

This list was generated on Sun May 29 13:53:28 2022 CEST.